Navigation Links
OHSU School of Dentistry team discovers new molecule in blood-pressure control system
Date:1/8/2009

PORTLAND, Ore. Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that the nerve cells controlling heart rate and blood pressure synthesize a molecule known to be critically important for proper nervous system growth. The finding could someday play a significant role in the prevention of Sudden Infant Death Syndrome (SIDS) and high blood pressure. According to the National Institutes of Health, SIDS is the leading cause of death in children between 1 month and 1 year of age. About one in three adults in the United States has high blood pressure.

The new discovery was published in a January issue of the Journal of Neurochemistry (vol. 108, pp. 450-464) and released online December 1, 2008 (www3.interscience.wiley.com.liboff.ohsu.edu/cgi-bin/fulltext/121542115/HTMLSTART). The Journal of Neurochemistry is a leading peer-reviewed neuroscience journal-.

"Our discovery sheds light on how the nerve supply to the cardiovascular system is established during development," said Agnieszka Balkowiec, M.D., Ph.D., principal investigator, OHSU School of Dentistry assistant professor of integrative biosciences and OHSU School of Medicine adjunct assistant professor of physiology and pharmacology. "Someday we hope to better understand cardiorespiratory developmental disorders such as SIDS."

Changes in blood pressure are signaled to the brain by nerve cells called baroreceptors. The OHSU study shows that baroreceptors make a molecule called Brain-Derived Neurotrophic Factor (BDNF), which belongs to the family of neurotrophins that play a critical role in the development and plasticity of other nerve cells. (Studies suggest that developmental abnormalities in nerve pathways that control the cardiovascular and respiratory system may result in SIDS).

Balkowiec and her team found that the stimulation of baroreceptors, as experienced during an increase in blood pressure, leads to the release of BDNF. The study also discovered that BDNF is present at the central end of baroreceptors in the brainstem.

"In fact, BDNF is likely to play the most important role at the central end of baroreceptors, where they connect to second-order neurons in the blood-pressure control pathway," said Balkowiec. "BDNF has previously been shown to play an important role in establishing neuronal connections in other parts of the nervous system, but this is the first time it has been considered a factor in the blood pressure control system."

Studies under way, in collaboration with Virginia Brooks, Ph.D., OHSU School of Medicine professor of physiology and pharmacology, indicate that levels of BDNF in cardiorespiratory nerve cells increase dramatically when blood pressure rises. This suggests a direct role of BDNF in regulation of blood pressure, said Balkowiec.


'/>"/>

Contact: Sydney Clevenger
clevenge@ohsu.edu
503-418-1792
Oregon Health & Science University
Source:Eurekalert

Related medicine news :

1. Time to Set Kids Back-to-School Sleep Clocks
2. Add Earlier Bedtime to Back-to-School List
3. Does Pathological Shyness Make for School Shooters?
4. Mailman School of Public Health study examines link between racial discrimination and substance use
5. Survey reveals disparities in skin cancer knowledge, protection among high school students
6. Non-medicinal treatment touted for pre-schoolers with ADHD
7. Nonmedicinal treatment touted for preschoolers with ADHD
8. Obese Children Miss More School Days
9. Back to School Means Backpack Safety
10. Heart Attacks at School Involve More Adults Than Kids
11. Back to School Means Return of School Blood Drives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. Clevens, MD, ... to welcome a new addition to their growing practice. Beginning this month, Teresa ... nurse practitioner performing cosmetic procedures including injectables, fillers and laser treatments. ...
(Date:2/9/2016)... ... February 09, 2016 , ... Steven Douglas Associates is a ... Florida Event, an upscale fundraiser held in South Florida. The Inaugural What’s Your Taste ... This year the event will be held in a new, more causal format at ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... production of its newest mobility device, the StandUp Walker. Made entirely in the ... in the last 50 years. , StandUp Walker’s novel patent-pending design offers 2-in-1 ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: ... stores, announced it has raised $176,000 to benefit the Breast Cancer Research Foundation, ... at the University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/9/2016)... Calif. , Feb. 9, 2016 /PRNewswire/ - Nevro ... company that is providing innovative evidence-based solutions for the ... release financial results for the fourth quarter and full ... 29, 2016. Company management will host a conference call ... Time) on Monday, February 29, 2016. www.nevro.com ...
(Date:2/9/2016)... 9, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today reported its fourth quarter and full year ... vivo therapeutic genome editing," said Edward Lanphier, ... finger nuclease (ZFN) technology leads the therapeutic genome ... competencies necessary to move our ground-breaking genome editing ...
Breaking Medicine Technology: